chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Pt reported swollen arm and pain still present 5 days later (1/3) though improving. Unable to tell is red.
I menstruated 3 days following the second dose in May 2021 after not having a menstrual cycle since July 2020. Normal menstruation with nothing remarkable. No additional cycle since.
This case was reported by a nurse via sales rep and described the occurrence of bone pain in a female patient who received SHINGRIX for prophylaxis. Previously administered products included ZOSTAVAX. On an unknown date, the patient received the 1st dose of SHINGRIX. On an unknown date, several hours after receiving SHINGRIX, the patient experienced bone pain, sickness, mobility decreased, pain in hip, muscle pain, nausea and fever. On an unknown date, the outcome of the bone pain, sickness, mobility decreased, pain in hip, muscle pain, nausea and fever were unknown. It was unknown if the reporter considered the bone pain, sickness, mobility decreased, pain in hip, muscle pain, nausea and fever to be related to SHINGRIX. Additional details were provided as follows: The age at vaccination was not reported. The patient worked in the clinic. The reporter stated that the patient's 1st dose experienced was not as bad as 2nd one. The patient received the shot mid afternoon and became very sick 8 hours later that and through the night. The patient could barely move because of pain. Her bones hurt (femur, hip, big bones) experienced muscle pain, nausea, and fever. Had a very difficult time working next day. The reporter agreed to be followed up.
Developed hive like rash 1-2 hours after receiving DTaP and Hep B. Hives lasted about 2 hours no respiratory or other problems reported.
-Tightness of chest after 15 minutes which lasted 24 hours. -Excessive thirst that lasted from 6-30 hours after the shot (including the need to drink several glasses of water in the night). -Tiredness the day after the vaccine.
Patient received an undiluted dose of the pediatric Pfizer Covid-19 vaccine in the ER pharmacy. The grandmother was notified approximately 2 hours later regarding the event since the mother was unavailable at the time. Despite multiple attempts to reach out, we have been unable to reach the mother to verify the status of the two children at this time.
expired vials were used to provide 38 doses of of the Moderna Covid-19 Vaccine.; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (expired vials were used to provide 38 doses of of the Moderna Covid-19 Vaccine.) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 049E21A) for COVID-19 vaccination.     No Medical History information was reported.    On 12-Nov-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 12-Nov-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (expired vials were used to provide 38 doses of of the Moderna Covid-19 Vaccine.). On 12-Nov-2021, EXPIRED PRODUCT ADMINISTERED (expired vials were used to provide 38 doses of of the Moderna Covid-19 Vaccine.) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant product use was not provided by the reporter Treatment information was not provided  vaccine expiration date was 11-OCT-2021.  No vial went any temperature excursions. vaccine  was administered within 2 hrs.   No adverse reactions to the vaccine reported.   Most recent FOLLOW-UP information incorporated above includes: On 19-Nov-2021: non significant follow up-Added Secondary reporter
Influenza IZ 11-13-07 at 1700; by 0400, 11-14-07, experiencing "severe, flu-like symptoms". Client called hospital and doctor advised not to take another flu iz. Has had no adverse reactions with past flu shots - notified public health at 10 AM, 11-14-07 - state" I'm fine now".
About 12 hours after receiving the vaccine, I vomited.; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) via COVID-19 Adverse Event Self-Reporting Solution (COVAES). The reporter is the patient. A 39 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administered in arm left, administration date 04Mar2021 09:30 (Batch/Lot number: unknown) at the age of 39 years as dose 1, single for covid-19 immunisation. Relevant medical history included: "penicillin allergy" (unspecified if ongoing). The patient's concomitant medications were not reported. Past drug history included: Clindamycin, reaction(s): "allergy". The following information was reported: VOMITING (non-serious) with onset 04Mar2021 21:00, outcome "recovered" (Mar2021), described as "About 12 hours after receiving the vaccine, I vomited.". Therapeutic measures were not taken as a result of vomiting. Additional information: The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine and no other medications were received within 2 weeks of vaccination. Prior to vaccination, the patient not diagnosed with COVID-19 and since the vaccination, the patient not been tested for COVID-19. This events were reported as non-serious. No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
After receiving vaccination (next day) noticed arm was hot and red. Look like fluid buildup between injection site and elbow. Arm stiff and sore. Was given influenza vaccine on same day but different arm. Patient brought reaction down with BENADRYL and cold compress.
Swollen, tender, erythematous matted axillary lymph nodes same arm as injection site. Arm sore near injection site. Mild flu-like symptoms.
Pt had initial local reaction with redness per Mom. 1st night after vaccine temp 100.6 - crying painful right leg. Cont. to have pain, + discomfort, sl. swelling no movement - Wed - slowly recovery over next 72 hours
DTaP given on 8/20/04, by that evening, pt had large area of left upper arm hot and swollen.
The initial case (from a contactable consumer) was missing the following minimum criteria: no adverse event. Upon receipt of follow-up information on 15Jun2015, this case now contains all required information to be considered valid. This is a spontaneous report from a non-clinical-study program from a contactable physician. A 51-year-old female patient received treatment with LYRICA 150 mg capsule oral from unspecified date to 01Jun2015 at 150mg twice daily, LIPITOR from unspecified date, VISTARIL 25mg capsule oral from 29May2015 at 25mg three times a day as needed for sleep, EFFEXOR XR 150 mg once daily, NEURONTIN 400 mg three times per day, and Prevnar. In the past the patient had an allergic reaction with LIPITOR and morphine. Additional medical history included headache and taking medication for sleep, rash, and cholesterol. Concomitant drugs included NEXIUM capsule delayed release oral 40 mg once daily as directed, BRINTELLIX tablet oral 10 mg once daily, atenolol 50 mg tablet oral at 50 mg once daily then at 1.5 tablet once a day, cyclobenzaprine tablet oral 10 mg twice a day as needed, MAXALT oral 5 mg tablet as needed (take one pill at onset of headache, repeat in 1 hour if needed), promethazine 12.5 mg tablet at 0.5 tablet oral three times a day as needed, simvastatin 40 mg tablet oral at 1 tablet every night for cholesterol, SYNTHROID oral 50 mcg once a day, VITAMIN B-12 250 mcg tablet, ZOFRAN oral 4 mg every eight hours as needed for nausea, CELEXA tablet oral 40 mg once a day discontinued on 29May2015, and FLEXERIL, atenolol, NYSTOP, BACTRIM, magnesium, promethazine, risperidone, simvastatin for cholesterol, trazodone, fluocinonide, cyclobenzaprine, MOBIC, NEXIUM, and Vitamin B-12. Drug allergies include Lipitor and morphine. On an unspecified date, while on pregabalin, hydroxyzine pamoate and atorvastatin sodium, the patient experienced nausea, sleep disorder and cholesterol level abnormal. Action taken with pregabalin, hydroxyzine pamoate and atorvastatin sodium was unknown. Outcome of the events was unknown. Follow-up (12AUG2015): Follow-up attempts completed. No further information expected. Follow-up (23Feb2016): New information reported from a Pfizer-sponsored program by a contactable physician includes: concomitant drugs data and new concomitant drug Flexeril. Follow-up attempts completed. No further information expected. Follow-up (12May2017): New information was received from a contactable physician reporting: additional concomitant therapy, medical history, and additional suspect medication of Lyrica, Lipitor, Prevnar, Vistaril, Neurontin, Effexor XR. Follow-up attempts are completed. No further information is expected.
Got vaccine and that night had worst headache of my life along with fever, chills, and general feeling of being sick. Took OTC pain reliever and woke up feeling slightly better the next morning. Over the next few weeks, I kept getting headaches, which is very out of the norm for me, as I hardly ever have them. OTC pain meds didn't help but they would come and go. Headaches began coming with much more frequency and intensity. Went and saw my PCP on 5/7/2021. She was concerned by the length of the headache without relief (it had been almost 1.5 weeks of a severe headache with no relief at this point, so she called in for me to have MRI). Pain intensified and become constant and excruciating. Ended up in the ER two times on 5/11 and 5/12. Pain was so severe I couldn't function, sleep, or eat. It felt like my head was going to explode and was WAY worse than natural childbirth, which I have gone through 3 times. Had CT Scan with contrast, normal results. Sent home with strong pain meds and gave referral to neurologist. Saw 2 neurologists they have high dose pain meds for me to take. These did help the headache slightly better but gave me stomach issues. Had MRI on 5/17, with normal results. Over the next month relied on family to help my family survive, as I mostly laid in bed. Finally began to feel better and was able to slowly wean off strong meds. Now I have sporadic headaches which are still out of the norm for me but not as intense as the May ones.
Information has been received from a physician concerning a 14 year old white female pt who may have been vaccinated with a dose of varicella virus vaccine live. It was noted that  the pt was not ill at the time of vaccination. The pt's mother called the physician's office to report that the pt had received the vaccine years ago but the physician was not sure that the pt had received it. Within the past week, on approx 11Jul05, the pt had a high fever, neck pain, and a rash all over her body with greater than 100 lesions. At the time of the report, the parent was going to take the pt to a hospital. Unspecified medical attention was sought. A product quality compliant was not involved. Follow up information was received from a physician who reported that he did not care for the pt and did not have details. He indicated that the mother of the pt was unsure when the pt was exposed to varicella, but there were some modified varicella cases in the area. It was noted that the pt was vaccinated nine to ten years ago. The pt was healthy with no past medical history. The pt presented with a high fever, numerous spots, many lesions, a severe headache, and a stiff neck. In the ER, the pt was diagnosed with anterior cervical adenopathy and varicella. The pt has subsequently recovered. Additional information was received from a physician who indicated that the child was vaccinated with varicella virus vaccine live when she was younger and just recently developed chickenpox. He indicated that there was no adverse event. Further information received from the physician indicated that the pt had developed varicella, not modified varicella as previously reported. She had greater than 100 lesions, fever, pruritis, vaginal/vulvar pain, and pruritis. She required anti viral therapy. It was noted that she recovered on 22Jul05. No additional information is expected.
First injection on 3/23, two small raised bumps presented on left thigh.  Itchy, but believed to be bug bites.  These remained and grew until 2nd injection on 4/20/21.  Around 4/23, the raised spots because inflamed and scaly, eventually with broken skin.  Treated with OTC hydrocortisone. Since this date, I have continued to suffer from patches of psoriasis on both thighs.  Since June I have been dealing with flare ups and patches on my torso, arms and legs.  I am self medicating with steroidal creme and salicylic topical creme but will be seeking medical treatment as the problem continues to worsen and with patches spreading.  Prior to my vaccination, I had mild eczema and psoriasis which was limited to my scalp and easily managed with OTC shampoos. I have  never had anything on my body (arms, legs or torso) prior to receiving my Moderna vaccination and I can't think of any changes in diet or lifestyle.
3rd full dose booster received 41 days after the second dose; Received 3rd full booster dose by error; This spontaneous case was reported by an other health care professional and describes the occurrence of INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (3rd full dose booster received 41 days after the second dose) and INCORRECT DOSE ADMINISTERED (Received 3rd full booster dose by error) in a 42-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 025L21B) for COVID-19 vaccination.     No Medical History information was reported.   On 29-Dec-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 02-Feb-2022, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 02-Feb-2022, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (3rd full dose booster received 41 days after the second dose). 02-Feb-2022, the patient experienced INCORRECT DOSE ADMINISTERED (Received 3rd full booster dose by error). On 02-Feb-2022, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (3rd full dose booster received 41 days after the second dose) and INCORRECT DOSE ADMINISTERED (Received 3rd full booster dose by error) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   It was reported that it was not sure if the patient was pregnant / breastfeeding while receiving the vaccine. When tried to enter the doses in the system, the system did not accept the DEC2021 dose as the first dose, so ended up recording it as the second dose and  recorded the FEB2022 dose as a full dose booster.  No concomitant and treatment medications were reported.   This case was linked to MOD-2022-476088 (Patient Link).
I expected some of these side effects for a day or so, but it has been 2 weeks as of yesterday and they are getting worse instead of better. Everything below started with the second dose and has not ended yet. Continued pain in left shoulder (injection site); swollen lymph nodes in both armpits; swollen glands in throat; sore throat; cough; nasal congestion; runny nose; headaches; pain in almost all joints; shooting pains in arms, legs, and abdomen; pain/pressure in sinus cavities; tiredness/fatigue; dizziness; confusion. For reference, I am that person that normally just sucks it up and moves on, which is why I haven't reported until now. I expected some side effects and I don't just lay down and give in, but this seems a bit excessive after 2 weeks.
On January 13,2022 - I experienced numbness on my lip (bottom lip) and 01/15-16 my whole lip was numb and tingling. On 1/17 - I woke up with my my whole right side (Face all the way to my toes on the right side) was numb and tingling - I also had paralysis on my left side. I called my doctor and was advised to go to the ER - and at the ER they ran a CT Scan to make sure I did not have a stroke and was diagnosed with Bell's Palsy and was advised to consult with my doctor and a neurologist. Up to this day 01/24/2022 I still have the same symptoms with no improvement.
IMMEDIATELY AFTER GIVING MMR SQ ON LT THIGH PT THIGH BECAME RED, SWOLLEN AND BLANCHING WAS NOTED DR NOTIFIED AND HE EXAMINED PT BENADRYL WAS GIVEN PT OBSERVED FOR 30 MINS. MOM INSTRUCTED TO APPLY COLD COMPRESSES AND GO TO ED IF GETS WORSE ALSO INSTRUCTED TO RETURN FOR FOLLOWUP APPT MADE NEXT MORNING AT 840. PT LT THIGH SITE SWELLING DECREASED BEFORE LEAVING PT STABLE UPON DISCHARGE CALLED MOM PT DOING FINE ALL REDNESS IS GONE MOM CANCELLED RETURN APPT
Immediately after injection I felt a tiny pinch in what felt like my heart.  I happened 2 more times within seconds and nothing else after that. I did not report this to anyone since it happened so quick and was over within a minute.  I did stay a few stay in the area where I had the injection just in case. After about 15 minutes I left because I felt fine. No other effects afterwards.
Was very tired and had sore muscles on September 09. Found September 10, 5:25 am dead. There were excessive amounts of blood along with large blood clots that appear to have come vaginally.
On day 9 after the first dose,  He Had an unprovoked seizure for the first time ever. He never had seizures his entire life. We took him to the emergency room , all tests were normal (including CT scan). Subsequently, he had his first-ever EEG that came back normal as well.
A report has been received from a Health Professional concerning a 5 year old, Female subject, who had been receiving FLUMIST quadrivalent (intranasal). FLUMIST quadrivalent (intranasal) started on 09-Dec-2014. It was reported that inadvertently administered expired FLUMIST quadrivalent to a patient (Lot: CH2023, Exp: Dec 1, 2014) which was started on 09-Dec-2014. The outcome of the event of inadvertently administered expired FLUMIST quadrivalent to a patient is unknown. The reporter was considered to be non-serious.
17feb71 @ 6 yr, pt had hx of limping & leg pain more than 2 wk p/ rubella vax on 22Jul70;10feb71 had pain & stiffness of rt knee;dx as myositis;1975 pt was dx as having Tourette's syndrome;
Positive for COVID after vaccination. Received 2nd dose of Moderna COVID vaccine on 2/10/21. On 4/18/21 became symptomatic. On 4/21/21 tested positive for COVID.
Case number PHEH2014US005129 is an initial spontaneous report received from a consumer on 17 Feb 2014 with a combined follow-up received from a nurse and quality assurance department (QA reference number: 301042) on 21 May 2014 and 22 May 2014 respectively. This report refers to a female patient whose age was not reported. Her medical history and concomitant medications were not reported. She was vaccinated with FLUCELVAX (batch number: 004011A, expiry date: Jun 2014) in the right deltoid on 15 Oct 2013. It was reported that on 04 Feb 2014, she had type A flu and she took off on most of the week. She checked with her physician on 05 Feb 2014 with fever, chills, fatigue, cough and congestion. She was told that she tested positive for influenza type A. The event outcome, seriousness and causality were not reported. A batch investigation was requested for FLUCELVAX batch number: 004011A, with QA reference number 301042. Combined follow-up received from a nurse and quality assurance department on 21 May 2014 and 22 May 2014 respectively: updated date of vaccination, onset date of event, added event "vaccination failure" and QA reference number.
Patient fainted, checked out by physician, given ibuprofen by RN. Sat for another 10min and left okay.
Abdominal pain lower right side; diarrhea; loss of appetite; spasms all unexplained; This is a spontaneous report from a contactable consumer reported for a patient. A patient of unspecified age and gender received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection.), dose 2 via an unspecified route of administration, administered in right arm on 24Mar2021 at 12:00 (Batch/Lot Number: ER8727) as DOSE 2, SINGLE, dose 1 via an unspecified route of administration, administered in right arm on 03Mar2021 at 12:00 (Batch/Lot Number: EN6205) as DOSE 1, SINGLE for COVID-19 immunization. Medical history included sinusitis from an unknown date and unknown if ongoing. Concomitant medication was not reported. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. No other medication received within 2 weeks of vaccination. No COVID prior vaccination. Patient had no known allergies. On 29Jul2021 at 13:00, the patient experienced abdominal pain lower right side, diarrhea, loss of appetite and spasms all unexplained. Seriousness criteria-results in death, life threatening, prolonged hospitalization, disabling/incapacitating and congenital anomaly/birth defect all were reported as no. Adverse event resulted in Doctor or other health care professional office/clinic visit, Emergency room/department or urgent care. No treatment received for adverse events. No COVID tested post vaccination. The patient underwent lab tests and procedures which included computerised tomogram, stool analysis normal (stool) and blood test (blood sample) all were normal. The outcome of the events were not recovered.; Sender's Comments: Linked Report(s) : US-PFIZER INC-202101098968 Same reporter/drug/event, different patient.
A few days following the vaccine,  Patient developed a mild rash. He then went to bed with perfectly aligned eyes and woke up with intermittent esotropia of his left eye which soon became alternating intermittent esotropia (strabismus).
Swelling, redness around injection site on left upper arm began with 24 hours of vaccine administration.
First noticed soreness, which progressed into signs of erythema with a lump above injection site with small bruise at injection site. Much redness with some swelling. Redness spread down the backside of the upper arm.
2nd vaccine triggered period weeks early; This is a spontaneous report from a non-contactable consumer (patient).   A non-pregnant 13-year-old female patient received BNT162B2 (PFIZER-BIOTECH COVID-19 VACCINE, solution for injection), via an unspecified route of administration on 30Jun2021 11:00 (at the age of 13 years old) as dose 2, single for COVID-19 immunisation. The patient's medical history included COVID-19 and concomitant medications were not reported. On 01Jul2021, the patient experienced 2nd vaccine triggered period weeks early with outcome of unknown. The facility type vaccine was reported as Pharmacy or Drug Store. Patient had no other vaccine in four weeks, no treatment for the events, and not COVID test post vaccination. The patient had COVID prior vaccination.   No follow up attempts are possible; Information about lot/batch number cannot be requested. No further information is expected.
26 y.o M complaining of lightheadedness, nausea, chest ?burning? and SOB approx. 10 min s/p reception of Pfizer COVID-19 mRNA Vaccine during the vaccine line. Initial vital signs + description of symptoms met criteria for anaphylaxis. Without delay he was given 0.3 mg of Epi via auto injector in the Left medial thigh (d/t vastus lateralis being obstructed by uniform items), as well as 50mg IM Benadryl in the R deltoid. He had an immediate improvement in VS an symptoms post epi (see vital signs documentation for pre/post intervention values). A warm handoff was given to EMS crew and transferred to ED.  ER doctor felt it was vasovagal reaction but member had no symptoms after receiving therapy.
pt states that after she took the vax upon leaving the clinic she started getting woozy and could feel the medicine going through her body all of the way down to her feet.  She felt like her heart rate was up. She sat down to relax before driving home.  Pt started taking ibuprofen immediately.  The next day her right arm was sore, some fatigue and slight fever.  All of her symptoms have subsided at this time.
Patient received the Bivalent vaccine for the second dose of her primary series, instead of the monovalent. No adverse reactions reported
I came out with hives all over my arms, chest, legs, back, shoulders, stomach with terrible itching.